openPR Logo
Press release

Severe Asthma Pipeline, Clinical Trials Key Companies - Teva Pharma, AstraZeneca, GSK

10-30-2023 01:28 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

DelveInsight's 'Severe Asthma Pipeline Insight, 2023" report by DelveInsight outlays comprehensive insights into the present clinical development scenario and growth prospects across the Severe Asthma market. A detailed picture of the Severe Asthma pipeline landscape is provided, which includes the disease overview and Severe Asthma treatment guidelines.

Download Sample Report to know more @ https://www.delveinsight.com/sample-request/severe-asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Severe Asthma Overview
Severe Asthma is a chronic condition of the lungs that involves inflammation and hyperactivity of the airways. With many symptoms and presentations, asthma can be triggered by breathing allergens from the environment such as pollen, dust, animal dander, mold, or other irritants. wheezing, shortness of breath, chest tightness or pressure, straining of neck and chest muscles, rapid breathing, and changes in heart rate.
Click here to learn more about the Severe Asthma Market Landscape @https://www.delveinsight.com/sample-request/severe-asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Key Highlights from the Severe Asthma Market Report
Key Companies working in the Severe Asthma market include Teva Pharmaceutical AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Roche Avalo Therapeutics, Connect Biopharmaceuticals, Pieris Pharma and many others
Key Therapies involved in the Severe Asthma market include Mepolizumab, Dupilumab, Reslizumab, Benralizumab and many others
Severe Asthma Treatment Market
Basic treatment for severe persistent asthma consists of inhaled corticosteroids. Additional long-term controller medicines, such as long-acting beta 2 agonists (LABA), montelukast or theophylline, are added if asthma is still uncontrolled.
Learn more about the treatment market for Severe Asthma @ https://www.delveinsight.com/report-store/Severe Asthma -market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Severe Asthma Epidemiology Segmented by:
Severe Asthma prevalent cases
Severe Asthma incident Cases
Severe Asthma treatment cases
Severe Asthma diagnosed cases
Severe Asthma Key Companies
Teva Pharmaceutical
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
And many others
Severe Asthma Key Therapies
Mepolizumab
Dupilumab
Reslizumab
Benralizumab
And many others
Learn more about the Key Companies and Emerging Therapies in the Severe Asthma Market @https://www.delveinsight.com/report-store/severe-asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Severe Asthma Introduction
Executive Summary of Severe Asthma
Disease Background and Overview
Severe Asthma Epidemiology and Patient Population
Severe Asthma Emerging Therapies
Severe Asthma Market Outlook
Severe Asthma Market Access and Reimbursement of Therapies
Severe Asthma Market Drivers
Severe Asthma Market Barriers
Appendix
Severe Asthma Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Severe Asthma Market Outlook report @ https://www.delveinsight.com/report-store/severe-asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Chronic Granulomatous Disease Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Severe Asthma Pipeline, Clinical Trials Key Companies - Teva Pharma, AstraZeneca, GSK here

News-ID: 3269162 • Views:

More Releases from DelveInsight Business Research LLP

Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Pipeline Analysis: 80+ Key Companies Shaping the Future of ALS Therapeutics | DelveInsight
Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Pipeline Analysis: 80+ Key Co …
DelveInsight's Amyotrophic Lateral Sclerosis (ALS) Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline ALS therapies in various stages of clinical development. The report provides insights into 80+ companies and 100+ pipeline drugs in the ALS pipeline landscape, covering clinical and nonclinical stage products, therapeutic assessments, and inactive pipeline products. Key takeaways from the ALS Clinical Trial Landscape Report • DelveInsight's ALS pipeline report depicts a robust space with
Polycythemia Vera Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Polycythemia Vera Therapeutics | DelveInsight
Polycythemia Vera Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping th …
DelveInsight's Polycythemia Vera Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline Polycythemia Vera therapies in various stages of clinical development. The report provides insights into 20+ companies and 25+ pipeline drugs in the Polycythemia Vera pipeline landscape, covering clinical and nonclinical stage products, therapeutic assessments, and inactive pipeline products. Key takeaways from the Polycythemia Vera Clinical Trial Landscape Report • DelveInsight's Polycythemia Vera pipeline report depicts a robust
Frontotemporal Dementia Clinical Trial Pipeline Analysis: 15+ Key Companies Shaping the Future of Frontotemporal Dementia Therapeutics | DelveInsight
Frontotemporal Dementia Clinical Trial Pipeline Analysis: 15+ Key Companies Shap …
DelveInsight's Frontotemporal Dementia Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline Frontotemporal Dementia therapies in various stages of clinical development. The report provides insights into 15+ companies and 20+ pipeline drugs in the Frontotemporal Dementia pipeline landscape, covering clinical and nonclinical stage products, therapeutic assessments, and inactive pipeline products. Key takeaways from the Frontotemporal Dementia Clinical Trial Landscape Report • DelveInsight's Frontotemporal Dementia pipeline report depicts a developing
The Global Skin Grafting Devices Market Size is projected to grow at a CAGR of 7.31% during the forecast period from 2025 to 2032 | DelveInsight
The Global Skin Grafting Devices Market Size is projected to grow at a CAGR of 7 …
The Skin Grafting Devices market is estimated to grow at a CAGR of 7.31% during the forecast period from 2025 to 2032, supported by rising burn and traumatic injury rates, a growing chronic wound burden, and continued technological advancement in dermatomes and grafting systems. DelveInsight's Skin Grafting Devices Market Insights Report 2032 provides current and forecast market analysis, individual leading Skin Grafting Devices companies' market shares, challenges, Skin Grafting Devices Market

All 5 Releases


More Releases for Severe

Severe Asthma Clinical Trial Pipeline Analysis: 30+ Key Companies Shaping the Fu …
DelveInsight's Severe Asthma Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline Severe Asthma therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Severe Asthma pipeline domain. Key takeaways from the Severe Asthma Clinical Trial Landscape Report • DelveInsight's Severe Asthma pipeline report depicts a robust space with 30+ active players working to develop 30+
Painkillers for particularly severe back pain
Not all back pain is mild. While many complaints subside after a few days with rest and mild painkillers, there are situations in which the intensity is significantly higher. Those affected describe stabbing, deep-seated or radiating pain that significantly restricts even simple movements. Particularly in cases of disc problems, severe muscle spasms or nerve root irritation, the strain can be so severe that targeted pain therapy is necessary. The aim is
PMS or PMDD? Understanding Severe Premenstrual Mood Changes
Many women notice mood shifts before their period. They may feel more emotional, tired, or irritable. This is often labeled PMS. For some, symptoms are mild and manageable. For others, they are intense and disruptive. When mood changes become severe, especially when they affect work, school, or relationships, it may be something more serious. That condition is called PMDD. Understanding the difference between typical premenstrual symptoms and a psychiatric condition can help
Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne Clinical Trials, Compan …
DelveInsight's "Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne, historical and forecasted epidemiology as well as the Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. DelveInsight's analysis highlights that several key companies are actively
Severe Combined Immunodeficiency (SCID) Market: A Comprehensive Overview
Severe Combined Immunodeficiency (SCID) is a rare but life-threatening genetic disorder that affects the immune system, leaving individuals vulnerable to infections. It is often referred to as "bubble boy disease," due to its dramatic impact on the immune system, which fails to protect the body from pathogens. SCID can be caused by various mutations in different genes, and it leads to a complete or near-complete absence of functional T-cells and
Severe Asthma Treatment Market - Revitalizing Quality of Life: Severe Asthma Tre …
Newark, New Castle, USA: The "Severe Asthma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Severe Asthma Treatment Market: https://www.growthplusreports.com/report/severe-asthma-treatment-market/8939 This latest report researches the industry structure,